Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment

Anil K. Jasti, Carlo Selmi, Juan C. Sarmiento-Monroy, Daniel A. Vega, Juan Manuel Anaya, M. Eric Gershwin

Producción científica: Contribución a una revistaArtículo de revisiónrevisión exhaustiva

98 Citas (Scopus)


Introduction: Guillain-Barré syndrome is a rare disease representing the most frequent cause of acute flaccid symmetrical weakness of the limbs and areflexia usually reaching its peak within a month. The etiology and pathogenesis remain largely enigmatic and the syndrome results in death or severe disability in 9–17% of cases despite immunotherapy. Areas covered: In terms of etiology, Guillain-Barré syndrome is linked to Campylobacter infection but less than 0.1% of infections result in the syndrome. In terms of pathogenesis, activated macrophages and T cells and serum antibodies against gangliosides are observed but their significance is unclear. Expert commentary: Guillain-Barré syndrome is a heterogeneous condition with numerous subtypes and recent data point towards the role of ganglioside epitopes by immunohistochemical methods. Ultimately, the syndrome results from a permissive genetic background on which environmental factors, including infections, vaccination and the influence of aging, lead to disease.

Idioma originalInglés estadounidense
Páginas (desde-hasta)1175-1189
Número de páginas15
PublicaciónExpert Review of Clinical Immunology
EstadoPublicada - nov. 1 2016

Áreas temáticas de ASJC Scopus

  • Inmulogía y alergología
  • Inmunología


Profundice en los temas de investigación de 'Guillain-Barré syndrome: causes, immunopathogenic mechanisms and treatment'. En conjunto forman una huella única.

Citar esto